Investing long-term in the cell & gene therapies of the future
Cell & Gene Therapy Insights 2023; 9(5), 299–303
Published: 28 March
David McCall, Senior Editor, BioInsights, speaks toGeeta Vemuri, Founder and Managing Partner, Agent Capital, about her VC company's portfolio of advanced therapy investments, and the keys to obtaining funding in a difficult environment. (From an interview conducted on February 22nd, 2023).